Endo Health Solutions Inc. is an American pharmaceutical company. It was created as a result of a management buyout from DuPont Merck in 1997. Three DuPont Merck executives (Carol A. Ammon, Chairman, President & CEO, and Mariann T. MacDonald, Executive Vice President, Operations, along with another colleague) purchased all of Endo Laboratories L.L.C.'s generic products along with 12 important brand products, including Percocet, Percodan, and Opana. The new company was called "Endo Pharmaceuticals Inc." On 23 May 2012, Endo's shareholders approved a resolution to change the company's name to "Endo Health Solutions Inc." - Source: Wikipedia
- News
- Policy
-
Commentary
- Commentary Main
- Corrections
- Editorials
- Letters
- Cheryl K. Chumley
- Kelly Sadler
- Jed Babbin
- Tom Basile
- Tim Constantine
- Joseph Curl
- Joseph R. DeTrani
- Don Feder
- Billy Hallowell
- Daniel N. Hoffman
- David Keene
- Robert Knight
- Gene Marks
- Clifford D. May
- Michael McKenna
- Stephen Moore
- Tim Murtaugh
- Peter Navarro
- Everett Piper
- Cal Thomas
- Scott Walker
- Miles Yu
- Black Voices
- Books
- Cartoons
- To the Republic
- Sports
- Sponsored
- Events
-
Video/Podcasts
- Corrections
- All Videos
- All Podcasts
- The Front Page
- Threat Status
- Politically Unstable
- The Sitdown with Alex Swoyer
- Bold & Blunt
- The Higher Ground
- Court Watch
- Victory Over Communism
- District of Sports
- Capitol Hill Show
- The Unregulated Podcast
- ForAmerica
- Washington Times Weekly
- God, Country & American Story
- Games
-
- Subscribe
- Sign In